Sydney Children's Hospital

Randwick, Australia

Description

The Kids Cancer Centre (KCC) at Sydney Children’s Hospital, Randwick (SCH) has been treating children for cancer and blood disorders in NSW, Australia and the Asia-Pacific region for over 50 years.  The Early Phase Clinical Trials Centre at the KCC works with scientists, physicians, pharmaceutical companies, and international collaborators to find the most promising results in laboratory research and translate these findings to benefit children with cancer. The primary focus is on children whose disease does not respond to standard therapy, or for whom no effective cure is available. By opening Phase I and Phase II trials, the Centre is able to offer potentially effective new treatments to these children.

Contact information

 

Kids Cancer Centre,

Sydney Children’s Hospital

Level 1, South Wing, High Street,

Randwick NSW 2031, Australia

Ph: (02) 9382 1111

Fax: (02) 9382 1789

E: SCHN-KCCCT@health.nsw.gov.au

Team

Principal Investigator

A/Prof David Ziegler, BSc (Med), MBBS, FRACP, MD/PhD

Paediatric Haematologist / Oncologist
A/Prof Ziegler is a paediatric oncologist at the Kids Cancer Centre, Sydney Children’s Hospital, Randwick. He treats children with all types of cancer and sub-specialises in childhood brain cancers, including malignant gliomas, DIPG and medulloblastomas. He is the Group Leader of the Brain Tumour Group at the Children’s Cancer Institute, Australia, focusing on development of novel targeted therapies for brain cancer, with a goal of rapid translation from laboratory to clinic. He leads the national childhood cancer personalized medicine trial.

A/Prof David Ziegler, BSc (Med), MBBS, FRACP, MD/PhD

Paediatric Haematologist / Oncologist